Changes in evaluation of the pepsinogen test result following Helicobacter pylori eradication therapy in Japan

被引：18

作者：

Kawai T. ^{[1
]}

Miki K. ^{[5
]}

Ichinose M. ^{[6
]}

Kenji Y. ^{[2
]}

Miyazaki I. ^{[2
]}

Kawakami K. ^{[2
]}

Kataoka M. ^{[1
]}

Yamagishi T. ^{[1
]}

Sofuni A. ^{[2
]}

Itoi T. ^{[2
]}

Moriyasu F. ^{[2
]}

Takagi Y. ^{[3
]}

Aoki T. ^{[3
]}

Matsubayashi J. ^{[4
]}

Mukai K. ^{[4
]}

机构：

[1] Endoscopy Center, Tokyo Medical University Hospital, Shinjuku-ku, Tokyo, 160-0023

[2] Fourth Department of Internal Medicine, Tokyo Medical University, Tokyo

[3] Third Department of Surgery, Tokyo Medical University, Tokyo

[4] Department of Pathology, Tokyo Medical University Hospital, Tokyo

[5] Department of Internal Medicine (Ohmori), School of Medicine, Toho University, Toho

[6] Second Department of Internal Medicine, Wakayama Medical University, Wakayama

来源：

Inflammopharmacology | 2007年 / 15卷 / 1期

关键词：

Eradication; Helicobacter pylori; Pepsinogen;

D O I：

10.1007/s10787-006-0009-y

中图分类号：

学科分类号：

摘要：

Aims: The pepsinogen (PG) test result is used in Japan for screening for gastric cancer. In this study, we investigated the changes in evaluation of the PG test result following H. pylori eradication. Methods: The subjects were 120 consecutive H. pylori-positive patients with upper gastrointestinal symptoms. Subjects underwent endoscopy prior to, and at 2 months after the eradication therapy, at which time blood was taken for determination of changes in PG levels. Results: The overall eradication rate was 79.3 % (per protocol). Following eradication therapy, the evaluation of PG test result converted from positive to negative in 80.4 % (37/46) of cases of successful eradication, and in 0 % (0/6) of cases of eradication failure. Conclusions: These results suggest that the evaluation of PG test result should be used after the definitive confirmation of the success or failure of H. pylori eradication therapy. © 2007 Birkhäuser Verlag.

引用

页码：31 / 35

页数：4

共 27 条

[1]

Cave T.R., Cave D.R., Helicobacter pylori stimulating pepsin secretion from isolated rabbit gastric glands, Scand. J. Gastroenterol, 26, SUPPL. 181, pp. 9-14, (1991)

[2]

Correa P., Human gastric carcinogenesis: A multistep multifactorial process. First American Cancer Society Award lecture on cancer epidemiology and prevention, Cancer Res, 52, pp. 6735-6740, (1992)

[3]

Dixon M.F., Genta R.M., Yardley J.H., Correa P., Classification and grading of gastritis the updated Sydney System, Am. J. Surg. Pathol, 20, pp. 1161-1181, (1996)

[4]

Furuta T., Kaneko E., Baba S., Arai H., Futami H., Percentage changes in serum pepsinogens are useful as indices of eradication of Helicobacter pylori, Am. J. Gastroenterol, 92, pp. 84-88, (1997)

[5]

Haruma K., Komoto K., Kamada T., Ito T., Kitadai Y., Yoshihara M., Sumii K., Kajiyama G., Helicobacter pylori is a major risk factor for gastric carcinoma in young patients, Scand. J. Gastroenterol, 35, pp. 255-259, (2000)

[6]

Ito M., Haruma K., Kamada T., Mihara M., Kim S., Kitadai Y., Sumii M., Tanaka S., Yoshihara M., Chayama K., Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: A 5-year prospective study of patients with atrophic gastritis, Aliment Pharmacol. Ther, 16, pp. 1449-1456, (2002)

[7]

Kawaguchi H., Haruma K., Komoto K., Yoshihara M., Sumi K., Kajiyama G., Helicobacter pylori infection is the major risk factor for atrophic gastritis, Am. J. Gastroenterol, 91, pp. 959-962, (1996)

[8]

Kikuchi S., Wada O., Nakajima T., Nishi T., Kobayashi O., Kinishi T., Inaba Y., Serum anti-Helicobacter pylori antibody and gastric carcinoma among young adults. Reaserch Group on Prevention of Gastric Caricinoma among Young Adalts, Cancer, 75, pp. 2789-2793, (1995)

[9]

Knight T., Greaves S., Wilson A., Hengels K., Newell D., Coelett M., Webb P., Forman D., Elder J., Variability in serum pepsinogen levels in an asymptomatic population, Eur. J. Gastroenterol. Hepatol, 7, pp. 647-654, (1995)

[10]

Kodoi A., Yoshihara M., Sumi K., Haruma K., Kajiyama G., Serum pepsinogen in screening for gastric cancer, J. Gastroenterol, 30, pp. 452-460, (1995)

← 1 2 3 →